The functional roles of m6A modification in T lymphocyte responses and autoimmune diseases

Cytokine Growth Factor Rev. 2022 Jun:65:51-60. doi: 10.1016/j.cytogfr.2022.04.004. Epub 2022 Apr 22.

Abstract

RNA N6-methyladenosine (m6A) modification is abundant in eukaryotes, bacteria and archaea. It is an RNA modification mainly existing in messenger RNA (mRNAs) and has a significant effect on the metabolism and function of mRNAs. m6A modification is controlled by three types of proteins, namely methyltransferase as the "writers", demethylase as the "erasers", and specific m6A recognized protein (YTHDF1-3) as the "readers". Recent studies have shown that m6A modification plays an important role in cancer, viral infection and autoimmune diseases. In this review, we will elaborate on the m6A modifications in the homeostasis and differentiation of T cells. Then we will further summarize the effects of m6A modification on the T cell responses and T cell-mediated autoimmune diseases. This will advance T cell epigenetics research and provide potential biomarkers and therapeutic targets for autoimmune diseases.

Keywords: Autoimmunity; Differentiation; T cell responses; m(6)A machinery.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / genetics
  • Adenosine / metabolism
  • Autoimmune Diseases*
  • Humans
  • RNA / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • T-Lymphocytes* / metabolism

Substances

  • RNA, Messenger
  • RNA
  • Adenosine